Ruolin Wu
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 5
- Oncology 4
- Cancer Immunotherapy and Biomarkers 2
- Cancer Cells and Metastasis 2
- Co-authors
- Lei Huang (2 shared papers)Aman Xu (1 shared paper)Hongchuan Zhao (9 shared papers)Xiaoping Geng (7 shared papers)Guobin Wang (8 shared papers)Fan Huang (7 shared papers)Xinghua Zhang (6 shared papers)Xiaojun Yu (2 shared papers)
- Journals
- Scandinavian Journal of Gastroenterology (1 paper)Frontiers in Oncology (1 paper)Functional & Integrative Genomics (1 paper)Applied Clay Science (1 paper)Scientific Reports (1 paper)
- Partner nations
- ChinaGermanyUnited States
In The Last Decade
Ruolin Wu
16 papers receiving 470 citations
Peers
Comparison fields: 5 of 59
- Hepatology 86
- Cancer Research 58
- Oncology 94
- Pulmonary and Respiratory Medicine 121
- Molecular Medicine 16
Countries citing papers authored by Ruolin Wu
This map shows the geographic impact of Ruolin Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruolin Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruolin Wu more than expected).
Fields of papers citing papers by Ruolin Wu
This network shows the impact of papers produced by Ruolin Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruolin Wu. The network helps show where Ruolin Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Ruolin Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Epithelial-mesenchymal transition in gastric cancer. | 2015 | 226 |
| 2 | 2021 | 63 | |
| 3 | 2016 | 43 | |
| 4 | 2018 | 31 | |
| 5 | Inhibitor of DNA binding proteins: implications in human cancer progression and metastasis. | 2018 | 28 |
| 6 | 2020 | 22 | |
| 7 | 2016 | 19 | |
| 8 | 2024 | 15 | |
| 9 | 2021 | 10 | |
| 10 | 2022 | 8 | |
| 11 | 2023 | 7 | |
| 12 | 2023 | 5 | |
| 13 | 2023 | 3 | |
| 14 | 2023 | 2 | |
| 15 | 2013 | 1 | |
| 16 | 2020 | 1 | |
| 17 | 2025 | 0 | |
| 18 | 2025 | 0 |
About Ruolin Wu
Ruolin Wu is a scholar working on Hepatology, Oncology, Cancer Research, Cell Biology and Pulmonary and Respiratory Medicine, having authored 18 papers that have together received 484 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (5 papers), Gallbladder and Bile Duct Disorders (3 papers), Proteoglycans and glycosaminoglycans research (2 papers), Cancer-related molecular mechanisms research (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Cancer Cells and Metastasis (2 papers), Hydrogels: synthesis, properties, applications (1 paper) and TGF-β signaling in diseases (1 paper). The work is most often cited by research in Hepatology (86 citations), Cancer Research (58 citations), Oncology (94 citations), Pulmonary and Respiratory Medicine (121 citations) and Molecular Medicine (16 citations). Ruolin Wu has collaborated with scholars based in China, Germany and United States. Frequent co-authors include Lei Huang, Aman Xu, Hongchuan Zhao, Xiaoping Geng, Guobin Wang, Fan Huang, Xinghua Zhang, Xiaojun Yu, Mohammed L. Abba and Rong Qin. Their work appears in journals such as Scandinavian Journal of Gastroenterology, Frontiers in Oncology, Functional & Integrative Genomics, Applied Clay Science and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.